Using loss-of-function and gain-of-function experiments, we showed that Adam2 expression had a dramatic effect on tumor growth by restricting type I and II IFN responses as well as several other cytokine signaling pathways thereby restraining the endogenous immune surveillance machinery, affecting predominantly T cells (please see schematic in Supplementary Fig. 38). This evidence concerns the gene SGCG and neoplasm.